Suchergebnisse - "Moin, Afrasim"

PubPharm (76)

1

An Update on Emergent Nano-Therapeutic Strategies against Pediatric Brain Tumors

enthalten in: Brain sciences | 2024

von Ravi Kiran, A. | Kumari, G. | Krishnamurthy, P. | +7

2

Targeting NF-κB signaling cascades of glioblastoma by a natural benzophenone, garcinol, via in vitro and molecular docking approaches

enthalten in: Frontiers in chemistry | 2024

von Rizvi, S. | Almazni, I. | Moawadh, M. | +10

3

Dual targeting multiwalled carbon nanotubes for improved neratinib delivery in breast cancer

enthalten in: RSC advances | 2023

von Abu Lila, A. | Bhattacharya, R. | Moin, A. | +6

4

Piperine-Loaded In Situ Gel : Formulation, In Vitro Characterization, and Clinical Evaluation against Periodontitis

enthalten in: Gels (Basel, Switzerland) | 2023

von Gopalakrishna, P. | Jayaramu, R. | Boregowda, S. | +7

5

Ocular Delivery of Bimatoprost-Loaded Solid Lipid Nanoparticles for Effective Management of Glaucoma

enthalten in: Pharmaceuticals (Basel, Switzerland) | 2023

von Satyanarayana, S. | Abu Lila, A. | Moin, A. | +5

6

Development and Characterization of Pullulan-Based Orodispersible Films of Iron

enthalten in: Pharmaceutics | 2023

von Gupta, M. | Kumar, T. | Reddy, D. | +9

7

Clinical Resistant Strains of Enterococci and Their Correlation to Reduced Susceptibility to Biocides : Phenotypic and Genotypic Analysis of Macrolides, Lincosamides, and Streptogramins

enthalten in: Antibiotics (Basel, Switzerland) | 2023

von Abu Lila, A. | Alharby, T. | Alanazi, J. | +8

8

Antibiotic-Loaded Gold Nanoparticles : A Nano-Arsenal against ESBL Producer-Resistant Pathogens

enthalten in: Pharmaceutics | 2023

von Rizvi, S. | Lila, A. | Moin, A. | +4

9

Nano-Conversion of Ineffective Cephalosporins into Potent One against Resistant Clinical Uro-Pathogens via Gold Nanoparticles

enthalten in: Nanomaterials (Basel, Switzerland) | 2023

von Rizvi, S. | Hussain, T. | Alshammari, F. | +7

10

Aloe-emodin exhibits growth-suppressive effects on androgen-independent human prostate cancer DU145 cells via inhibiting the Wnt/β-catenin signaling pathway : an in vitro and in silico study

enthalten in: Frontiers in pharmacology | 2023

von Hussain, T. | Alafnan, A. | Almazni, I. | +11

1
2
3
4
5
6
7
8
Nächster »
[8]